61364-37-2,
UNII-0UF1VD57JD,
(R)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine,
0UF1VD57JD,
(7R)-5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene,
(R)-Mirtazapine,
(-)-Mirtazapine,
R-(-)-Mirtazapine,
R-Mirtazapine,
Org 44-19,
EINECS 262-735-5,
AC1Q3ZYK,
AC1MJ43I,
ZINC509,
MLS001165757,
BIDD:GT0798,
CHEMBL608847,
SCHEMBL8271559,
Org-44-19,
CHEBI:94765,
CTK2F8485,
DTXSID80210281,
HMS2231D15,
HMS3259D15,
PDSP1_001531,
PDSP2_001515,
AKOS030254936,
MCULE-1894397344,
NC00656,
NE40615,
CPD000550486,
SAM002548934,
SMR000550486,
EN300-59238,
Z1258578357,
UNII-A051Q2099Q component RONZAEMNMFQXRA-INIZCTEOSA-N,
(R)-2-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine,
(7R)-5-methyl-2,5,19-triazatetracyclo[13.4.0.0(2),.0,(1)(3)]nonadeca-1(19),8,10,12,15,17-hexaene,
(7R)-5-methyl-2,5,19-triazatetracyclo[13.4.0.0?,?.0?,??]nonadeca-1(19),8,10,12,15,17-hexaene,
mirtazapine,
Mirtazapine, (R)-,
C17H19N3,
C17-H19-N3,
CID3085219,
B2113,
A11702,
85650-52-8,
(R)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine,
-1,2,3,4,10,14b-hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine,